China Biomedical Fund Phase I appeared to be the VC, which was created in 2014.
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019.
Among the most popular portfolio startups of the fund, we may highlight Sumgen Biotech. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Clinical Trials.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the China Biomedical Fund Phase I, startups are often financed by Jianxin Capital.
Related Funds
| Fund Name | Location |
| Anterra Capital | Amsterdam, Noord-Holland, The Netherlands |
| Cascadia Pacific | Kirkland, United States, Washington |
| Chuangke Accelerated Investment | China, Hangzhou, Zhejiang |
| DRS | Chiyoda, Japan |
| Fingerhut Ventures | Eden Prairie, Minnesota, United States |
| Gaz de France | - |
| Maropost Ventures | - |
| SCP Worldwide | New York, New York, United States |
| Siena Holding | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sumgen Biotech | 21 Feb 2019 | Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sumgen Biotech | 21 Feb 2019 | Zhejiang |
